OCT has obtained regulatory approval for the phase III study in ophthalmology in Russia
The Ministry of Health of Russia approved a Phase III Study in ophthalmology.
These are multicenter, randomized, double-blind , placebo-controlled phase III studies, the primary goal of which is to evaluate the efficacy of the study medicine vs. active comparator.
It is planned to recruit 65 male and female patients aged from 18 to 65 with glaucoma or ocular hypertension in 7 sites in SPB, Moscow, Ufa and Saratov.
Within this project, OCT team is responsible for a scope of services including site selection, project management, data management, clinical and medical monitoring and final report preparation, logistics.